Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
4 followers
Gilead Sciences
198 followers
Regeneron
164 followers
Illumina
86 followers
Agilent Technologies
95 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
53 followers